Evidence map›Paper›PMID 31691133›Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020

Impact of a Formulation Containing Unusual Polyunsaturated Fatty Acids, Trace Elements, Polyphenols and Plant Sterols on Insulin Resistance and Associated Disturbances.

María J Peláez-Jaramillo, Natalia Valencia-Enciso, Allison A Cárdenas-Mojica, Paula V Gaete, Eitan A Scher-Nemirovsky, Luisa F Gómez-Arango, Daniel Colmenares-Araque, Camilo A Castro-López, Eddy Betancourt-Villamizar, Jesús Jaimes-Madrigal and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03512665 (Impact of a Supplement of Vegetable Oils on Body Weight and Composition, Insulin Sensitivity and Other Cardiovascular Risk Factors in People at Risk of Developing Type 2 Diabetes Mellitus.), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03512665 nacompletednot on this map

Impact of a Supplement of Vegetable Oils on Body Weight and Composition, Insulin Sensitivity and Other Cardiovascular Risk Factors in People at Risk of Developing Type 2 Diabetes Mellitus.

TypeinterventionalSponsorUniversity of Los Andes, ColumbiaRan2018 to 2018Enrolled25ConditionsInsulin ResistanceArmsFull dose supplement, Low dose Supplement, Control Oil
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 2 countries.

María J Peláez-JaramilloSchool of Medicine, Universidad de los Andes, Bogotá, Colombia.
Natalia Valencia-EncisoSchool of Medicine, Universidad de los Andes, Bogotá, Colombia.
Allison A Cárdenas-MojicaSchool of Medicine, Universidad de los Andes, Bogotá, Colombia.
Paula V GaeteSchool of Medicine, Universidad de los Andes, Bogotá, Colombia.
Eitan A Scher-NemirovskySchool of Medicine, Universidad de los Andes, Bogotá, Colombia.
Luisa F Gómez-ArangoTeam Foods Colombia, S.A., Bogotá, Colombia.
Daniel Colmenares-AraqueTeam Foods Colombia, S.A., Bogotá, Colombia.
Camilo A Castro-LópezTeam Foods Colombia, S.A., Bogotá, Colombia.
Eddy Betancourt-VillamizarTeam Foods Colombia, S.A., Bogotá, Colombia.
Jesús Jaimes-MadrigalTeam Foods Colombia, S.A., Bogotá, Colombia.
Carlos A AlvarezTeam Foods Colombia, S.A., Bogotá, Colombia.
Mario A Jiménez-MoraSchool of Medicine, Universidad de los Andes, Bogotá, Colombia.
Pedro J Quiroga-PadillaSchool of Medicine, Universidad de los Andes, Bogotá, Colombia.
Danna K Puerto-BaracaldoSchool of Medicine, Universidad de los Andes, Bogotá, Colombia.
Carlos O MendivilSchool of Medicine, Universidad de los Andes, Bogotá, Colombia. cmendivi@uniandes.edu.co.ORCID http://orcid.org/0000-0001-5546-4206
Universidad de Los Andes · CO

Funding

Team Foods Colombia 111-2017
6 · The paper itself

Abstract

introductionTo evaluate the effect of a lipid-based formulation containing unusual polyunsaturated fatty acids, trace elements, polyphenols and plant sterols on insulin resistance and its associated disturbances among adults at risk of diabetes.

methodsThis was an 8-week, three-arm, open-label randomized clinical trial. We studied individuals aged ≥ 18 years old with diabetes risk given by a body mass index ≥ 25 kg/m

resultsWe randomized 25 individuals. After one withdrawal in the high-dose group, the study sample comprised nine patients in the control, nine in the low-dose and six in the high-dose groups. The insulin sensitivity increased significantly and in a dose-dependent fashion, up to 10% in the high-dose group. At week 8 the low-dose group exhibited lower glycemic excursions during the oral glucose tolerance test (OGTT), especially 1 h after the glucose challenge (32 mg/dl or 23% lower vs. control group). The incremental area under the glucose curve in the OGTT was 17.1% lower in the low-dose group vs. the control group. Waist circumference increased in the control group, remained constant in the low-dose group and decreased in the high-dose group. C-reactive protein decreased in both formulation groups, up to 50% in the high-dose group. Participants in the formulation groups exhibited increased secretion of GLP-1 and plasma irisin at week 8 vs. the control group.

conclusionThe formulation induced favorable changes in insulin sensitivity, glucose tolerance, abdominal obesity and inflammation. These effects and their durability will need to be assessed in larger studies.

trial registrationNCT03512665.

fundingTeam Foods Colombia.

Indexed as

AdipokinesDiabetesFatty acidsGastrointestinal hormonesInsulin resistanceMetabolic syndrome

Identifiers

PMID31691133
PMCPMC6965541
OpenAlexW2983344662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.